KIT and lung cancer: Significant increase in STAT3 expression in NK cells in lung cancer patients, revealed in our studies, can be associated with c‐kit and c‐myc down‐regulation in the same cells, since STAT3 executes the downstream signaling from these proto‐oncogenes.